PATENT CLAIM ANALYSIS

Application Number: 16251617
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "001110"]

Abstract:
Methods of treating cancer by administering a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments are described, wherein R 1  is halo; R 2  is halo; and Q is CH or N.

Claim (Index 7):
The method according to any one of  claims 1  and  3 - 6 , wherein the one or more additional treatment(s) is radiation.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 99.0
- Lexical Diversity: 1.33333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13145054', '14340871', '13249815', '11753514', '12393806']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8079188034328936
- 35 USC 102 Novelty (BERT): 0.5101512546907987
- Combined Prediction Score: 0.7781420485586841
- Mean Citation Score: 338.013512
- Max Citation Score: 351.83926
- Similarity Product: 202.92603356071712

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test